JAC-Antimicrobial Resistance (JAC-AMR)

JAC-Antimicrobial Resistance (JAC-AMR) is a fully open access Society journal from the British Society for Antimicrobial Chemotherapy (BSAC). As one of the most important threats to global health, antimicrobial resistance requires an innovative, interdisciplinary response. The mission of JAC-AMR is to disseminate cutting-edge research, and provide education regarding the origins, spread, characteristics, diagnosis, treatment, and prevention of multi-drug resistant organisms that result in difficult-to treat infections around the world. We publish original research articles, reviews, clinically oriented opinions and viewpoints, debates, brief reports, and reviews of educational resources. JAC-AMR focuses on advancing the science and knowledge of antimicrobial resistance, stewardship and use relating to antibacterial, antifungal, antiviral and antiprotozoal agents. The Journal recognizes the importance of the “One Health” framework to understand AMR, and encourages AMR investigations that cover the spectrum of environment, animal and human health. JAC-AMR is dedicated to the dissemination of research on antimicrobial stewardship practices, and encourages the use of rigorous non-quantitative methodology where appropriate.

JAC-Antimicrobial Resistance (JAC-AMR) is :-

• International, Peer-Reviewed, Open Access, Refereed, Pathology, Clinical Medicine, Microbiology, Immunology, Infectious Diseases, Immunology and Allergy , Online , Yearly Journal

• UGC Approved, ISSN Approved: P-ISSN E-ISSN: 2632-1823, Established: 2019,
• Provides Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE